John Pacifico

John Pacifico is a partner and CFO at Canaan, an early-stage venture capital investment firm. Prior to joining Canaan, John was the president, CEO, and a member of the board of directors at ORTHOCON, a company that develops targeted drug delivery products for use during surgical procedures. John has also held leadership positions at Abyrx, Kairuku, Inc., and Transposon Therapeutics.

John Pacifico has a Bachelor of Science from the Charles F. Dolan School of Business at Fairfield University and an MBA from Columbia University. John is currently a Kauffman Fellow.